1 Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008
2 The aim of our study was to investigate the etiology and treatment of chronic bacterial prostatitis, especially the significance of Chlamydia trachomatis and Ureaplasma urealyticum in prostatitis syndrome and the possibilities for treatment.
3 This research is a part of several scientific research projects of the Ministry of Science, Education and Sports of the Republic of Croatia: Urogenital infections caused by C. trachomatis (no ) Etiology and treatment of chronic prostatitis (no ) Clinical significance of urogenital mycoplasma (no ) Diagnosis and treatment of patients with prostatitis syndrome (no )
4 The study was conducted at the Outpatient Department for Urogenital Infections, University Hospital for Infectious Diseases Dr Fran Mihaljevic Zagreb, Croatia, between March 1, 1999 and June 30, The Ethics Committee of the Hospital approved the study. An informed consent was signed by all the patients.
5 PATIENTS In the 9 year study, we examined a total of 3029 patients over 18 years of age with symptoms of chronic prostatitis and no evidence of structural or functional lower genitourinary tract abnormalities.
6 The inclusion criteria for chronic prostatitis was the duration of symptoms for at least 3 months. The patients complained of one or more of the following symptoms: urethral symptoms (voiding dysfunction, urinary urgency, frequency, nocturia, dysuria) prostatic symptoms (pain and discomfort in the low back and in the perineal, suprapubic, penile, scrotal, or groin areas) sexual symptoms (pain during or after ejaculation or erectile dysfunction)
7 METHODS The following data were obtained for each patient: - medical history - clinical status - digitorectal prostatic examination - urethral swab specimens - selective samples of urine and EPS (Meares and Stamey 4-glass localization technique) - the severity of chronic prostatitis symptoms scored by the Croatian translation of the NIH-CPSI questionnaire was performed in only a small number of patients
8 METHODS Urethral swab specimens were examined for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis.
9 METHODS Quantitative segmented cultures and bacterial identification as well as the number of leukocytes were determined in three voided urine samples (first voided- VB 1, midstream - VB 2, and urine bladder sample collected immediatelly after prostatic massage - VB 3 ) and expressed prostatic secretion (EPS). (Standard microbiological methods, Clinical Microbiology Laboratory of the Hospital)
10 METHODS EPS or VB 3 were examined for the presence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Trichomonas vaginalis.
11 METHODS Urogenital mycoplasma Trichomonas vaginalis Chlamydia trachomatis semiquantitative culturing antimicrobial susceptibility test Mycoplasma duo and S.I.R. Mycoplasma test (Clinical Microbiology Laboratory of the Hospital) culturing on DIAMOND modified medium (Clinical Microbiology Laboratory of the Hospital) isolation on McCoy cells Lugol stain ( ) immunofluorescent typing with monoclonal antibodies ( onging); (Croatian Institute for Public Health, Zagreb, Croatia) DNA/RNA Digene hybridization method (Clinical Microbiology Laboratory of the Hospital)
12 The diagnostic criteria for chronic bacterial prostatitis were as follows: - presence of clinical symptoms, - presence of 10 WBC s /hpf in EPS or VB 3 - a bacterial count of 10 3 cfu/ml or more, - if only Gram-positive cocci are found in EPS, a bacterial count of 10 4 cfu/ml or more is required, - finding of ten or many times greater number of bacteria in EPS or VB 3, than VB 1 or VB 2.
13 The diagnostic criteria for chronic prostatitis caused by C. trachomatis were: -presence of clinical symptoms, -presence of 10 WBCs /hpf in EPS or VB 3 -presence of C. trachomatis in EPS or VB 3 -absence of C. trachomatis in urethral swabs -absence of other possible pathogens of chronic prostatitis in urethral swabs, EPS or VB 3.
14 The diagnostic criteria for chronic prostatitis caused by U.urealyticum or M.hominis were: -presence of clinical symptoms, -presence of 10 WBCs /hpf in EPS or VB 3, -presence of U. urealyticum or M. hominis in EPS or VB 3, -absence of U. urealyticum or M. hominis in urethral swabs, -absence of other possible pathogens of chronic prostatitis in urethral swabs, EPS or VB 3
15 The diagnostic criteria for nonbacterial prostatitis or inflammatory chronic pelvic pain syndrom were: - presence of clinical symptoms, - presence of 10 WBCs /hpf in EPS or VB 3, - absence of possible bacterial pathogens of chronic prostatitis in EPS or VB 3, - presence of Trichomonas vaginalis in EPS or VB 3
16 The diagnostic criteria for non-inflammatory chronic pelvic pain syndrome were: - presence of clinical symptoms, - no white cells in EPS or VB 3 - absence of possible pathogens of chronic prostatitis in EPS or VB 3
17 RESULTS The etiology of chronic prostatitis syndrome in patients treated at the University Hospital for Infectious Diseases Dr Fran Mihaljevic from 1999 to 2008 Microorganism confirmed Patients in EPS or VB 3 > 10 WBCs/hpf in EPS < 10 WBCs/hpf in EPS Total no. no. (%) no. (%) no. (%) Chlamydia trachomatis 302 (15,46) 465 (43,26) 767 (25,16) Trichomonas vaginalis 211 (10,80) 101 (9,40) 312 (10,30) Ureaplasma urealyticum 158 (8,09) 63 (5,86) 221 (7,30) Escherichia coli 213 (10,90) 20 (1,86) 233 (7,69) Enterococcus 173 (8,85) 29 (2,70) 202 (6,67) Proteus mirabilis 73 (3,74) 7 (0,65) 80 (2,64) Klebsiella pneumoniae 34 (1,74) 4 (0,37) 38 (1,25) Streptococcus agalactiae 37 (1,89) 12 (1,12) 49 (1,62) Pseudomonas aeruginosa 5 (0,26) 2 (0,19) 7 (0,23) Mycoplasma hominis 15 (0,77) 12 (1,12) 27 (0,89) Staphylococcus aureus 2 (0,10) 2 (0,19) 4 (0,13) Mixed infection 74 (3,79) 31 (2,88) 105 (3,47) None 657 (33,62) 327 (30,42) 984 (32,49) Total
18 A high incidence of etiologically confirmed chronic prostatitis syndrome cases, especially high percentage of sexually transmitted pathogens, can be explained through: - selective population referred to our outpatient department due to a suspected urogenital or sexually transmitted infection - regular analysis in these patients for the presence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Trichomonas vaginalis with the most sophisticated microbiological methods
19 In the period from 1999 until 2006, a total of 389 patients with chronic bacterial prostatitis were treated with azithromycin: patients with chronic prostatitis caused by Chlamydia trachomatis - 82 patients with chronic prostatitis caused by Ureaplasma urealyticum
20 Azitromycin total dose 4.0 g 4.5 g 6.0 g Comparative drugs Ciprofloxacin Clarithromycin Doxycycline Antimicrobial treatment in 389 patients
21 Clinical efficacy and tolerability of administered drug as well as possible adverse events were evaluated during, at the end, and at 4-6 weeks of therapy completion. Clinical response definitions: Cure complete resolution of urethral, prostatic and sexual symptoms Improvement incomplete resolution of urethral, prostatic or sexual symptoms, but no need for additional therapy; and Failure no apparent response or progression of urethral, prostatic or sexual symptoms, or additional antibiotic therapy needed.
22 Bacteriologic efficacy of the administered drug was evaluated at 4-6 weeks of therapy completion using methods identical to those used on study enrolment. Bacteriologic response definitions: Eradication eradication of Chlamydia trachomatis or Ureaplasma urealyticum at post-treatment visit; and Persistence persistence of Chlamydia trachomatis or Ureaplasma urealyticum at post-treatment visit
23 Published papers Škerk V, Schönwald S, Krhen I, et al. Azithroymcin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;13: Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;14: Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Škerk V, Krhen I, Lisić M, et al. Azithromycin: 4.5 or 6.0 gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis a randomized study. J Chemother 2004;16: Škerk V, Krhen I, Lisić M, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24:
24 Published papers 6. Škerk V, Čajić V, Markovinović L, et al. Azithromycin in the treatment of prostatitis caused by U.urealyticum. Medicus 2006;15: Škerk V, Mareković I, Markovinović L, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection cuased by Ureaplasma urealyticum. Chemotherapy 2005;52: Škerk V, Markovinović L, Zekan S, et al. The significance of Chlamydia trachomatis in urethritis and prostatitis differences in therapeutic approach Croatian experience. J Chemotherapy Feb 2009 in press 9. Škerk V, Roglić S, Čajić V, et al. Comparison of clinical symptoms scored by the National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI) and laboratory results for the assessment of clinical and bacteriological efficacy of antimicrobial treatment in patients with chronic prostatitis syndrome. J Chemotherapy Apr 2009 in press
25 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002;14: Bacteriological evaluation of azithromycin and clarithromycin efficacy in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis Bacteriological evaluation Antimicrobial treatment AZITHROMYCIN CLARITHROMYCIN 4.5 g / 3 weeks 2 x 500 mg / 15 days n (%) n %) Eradication 37 (80.43) 36 (80.00) Persistence 9 (19.57) 9 (20.00) T O T A L P=0,83
26 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002;14: Clinical evaluation of azithromycin and clarithromycin efficacy in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis Clinical evaluation Cure Failure Antimicrobial treatment AZITHROMYCIN CLARITHROMYCIN 4.5g / 3 weeks 2 x 500 mg / 15 days n (%) n (%) 32 (69.57) 14 (30.43) 32 (71.11) 13 (28.89) T O T A L P=0,946
27 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Bacteriological evaluation of azithromycin and ciprofloxacin efficacy in the treatment of chronic chlamydial prostatitis Efficacy P=0,0002 Patients treated with azithromycin (n=45) 36 (80%) 9 (20%) Patients treated with ciprofloxacin (n=44) 17 (38,64) 27 (61,36) Eradication Persistence TOTAL 45 44
28 Škerk V, Schönwald S, Krhen I i sur. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21: Clinical efficacy of azithromycin and ciprofloxacin in the treatment of chronic chlamydial prostatitis Efficacy Cure Improvement Failure P=0,0021 Patients treated with azithromycin (n=45) 31 (68, 89%) 4 (8,89%) 10 (22,22%) Patients treated with ciprofloxacin (n=44) 15 (34,09%) 7 (15,91%) 22 (50%) TOTAL 45 44
29 Škerk V, Krhen I, Lisić M i sur. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24: Bacteriological evaluation of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by C. trachomatis Efficacy Patients treated with azithromycin (n=82) Patients treated with doxycycline (n=43) Eradication 65 (79,27%) 33 (76,74%) Persistence 17 (20,73%) 10 (23,26%) TOTAL P=0,82
30 Škerk V, Krhen I, Lisić M i sur. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24: Clinical efficacy of azithromycin and doxycycline in the treatment of prostate infection caused by C. trachomatis Efficacy Patients treated with azithromycin (n=82) Patients treated with doxycycline (n=43) Cure 56 (68,29%) 30 (69,77%) Improvement 3 (3,66%) 2 (4,65%) Failure 23 (28,05%) 11 (25,58%) TOTAL P=0,94
31 Comparison of the efficacy of different doses of azithromycin in the treatment of 307 patients with chronic chlamydial prostatitis EFFICACY AZITHROMYCIN n=82 4,0 g total 1x1g po. per week 4 weeks ANTIMICROBIAL THERAPY AZITHROMYCIN n=182 4,5 g total 1x500 mg po. 3 days per week 3 weeks AZITHROMYCIN n=43 6,0 g total 1x1g po per week 6 weeks BACTERIOLOGICAL ERADICAT ION 65 (79%) 151 (83%) 35 (81%) PERSISTENCE CLINICAL CURED 56 (68%) 124 (68%) 31 (72%) NOT CURED
32 Efficacy of azithromycin and doxycycline in the treatment of chronic prostatitis caused by U.urealyticum ANTIMICROBIAL THERAPY EFFICACY BACTERIOLOGICAL ERADICATION PERSISTENCE CLINICAL CURED NOT CURED AZITHROMYCIN n=32 4,5g total 1x500mg po. 3 days per week 3 weeks DOXYCYCLINE n=31 2x100mg po. 21 days P=0,77 P=1,0
33 CONCLUSION Azithromycin is an efficient and safe antimicrobial drug for the treatment of chronic prostatitis caused by C.trachomatis. It is recommended: In a total dose of 4.5 g po. during 3 weeks, administered for 3 days in doses 1x500mg per day OR In a total dose of 4.0 g po. during 4 weeks, administered in a single dose of 1x1.0 g per week
34 CONCLUSION Azithromycin is efficient and safe antimicrobial drug for the treatment of chronic prostatitis caused by U.urealyticum. It is recommended In a total dose of 4.5g po. during 3 weeks, administered for 3 days in dose 1x500mg per day
A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections By Gary R. Skankey, MD, FACP, Infectious Disease, Las Vegas, NV Sponsored
Prostatic Diseases Diagnosis and Treatment of Prostatitis JMAJ 47(12): 561 565, 2004 Takashi DEGUCHI Professor, Department of Urology, Gifu University School of Medicine Abstract: Among various prostatic
Prostatitis What is prostatitis? Prostatitis is a condition that involves inflammation of the prostate and sometimes the area around it. There are several types of prostatitis, each with a range of symptoms.
Chronic and Chronic Pelvic Pain Syndrome PROSTATITIS is a clinical syndrome. It afflicts men as early as twenty (20) years of age up to as late as 70 years and older. There are four major signs and symptoms:
GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2010) M. Grabe (chairman), T.E. Bjerklund-Johansen, H. Botto, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction Infections
for UTI: The Burning Question of Self Diagnosis Overview Review Pharmacist prescribing in Saskatchewan Discuss current management / diagnosis of UTI Appraise the literature for safe and accurate diagnosis
URINARY TRACT INFECTIONS TO TREAT OR NOT TO TREAT Eddie Grace, Pharm.D.,BCPS,AQ-ID, AAHIVE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy October 20 th, 2011 Objectives
Š. Zekan 1, M. Youle 2, O. Đaković Rode 1, S. Židovec Lepej 1, M. Kosanović 1, J. Begovac 1 1 University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia 2 Royal Free Hospital & JUSTRI
Prostatitis Common Most common urological problem in men < 50 yrs Third most common problem in men > 50yrs Represents 3% to 12% of male outpatient visits to urologists All ages affected Worldwide distribution
Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate
Catheter-Associated Urinary Tract Infection () Event Introduction: Urinary tract infections (UTIs) are tied with pneumonia as the second most common type of healthcare-associated infection, second only
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora
Male Chronic pelvic pain syndrome Dr. Kan Chi Fai Associate Consultant Queen Elizabeth Hospital What patient groups are included in Prostatitis? this topic? Patients with perineal pain? Patients with LUTS?
Chlamydia - uncomplicated genital - Management View full scenario When should I suspect and test for chlamydia? Women: o Test for chlamydia if they are sexually active with symptoms and signs suggesting
The Journal of International Medical Research 2008; 36: 244 252 Tamsulosin Treatment of Chronic Non-bacterial Prostatitis ZQ YE, RZ LAN, WM YANG, LF YAO AND X YU Department of Urology, Tongji Hospital,
Mindanao Journal of Science and Technology Vol. 12 (2014) 171-178 Difference on the Incidence of Urinary Tract Infection (UTI) between Diabetic and Non-diabetic Women Admitted in Metro Cebu, Philippines
The Journal of International Medical Research 1995; 23: 386-393 The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin T ERDOGRU\ A AGA9FIDAff, M ONELz,S BADUR z, 0 ANG 2 AND S TELALLOGLU
Edward W. Hook, III, M.D. The Medical Value of Laboratory Edward W. Hook III M.D. Departments of Medicine. Microbiology and Epidemiology University of Alabama at Birmingham Grant/Research Support: Consultant:
ORIGINAL PAPER DOI: 10.4081/aiua.2013.4.190 Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of
Adult Inclusion Conjunctivitis Dr. Victor Malinovsky 2006 General Characteristics Chlamydia are obligate intracellular parasites, C. trachomatis causes inclusion conjunctivitis, trachoma, cervicitis (women)
Chronic Prostatitis: Patient information There are two main types of chronic prostatitis - chronic bacterial prostatitis (caused by chronic bacterial infection) and chronic prostatitis/chronic pelvic pain
Case Studies in Urinary Tract Infections Robert L. Holley, MSc, MD Professor of Obstetrics and Gynecology Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology
Urinary Tract Infections Leading cause of morbidity and health care expenditures in persons of all ages. An estimated 50 % of women report having had a UTI at some point in their lives. 8.3 million office
How to Make Adolescent STD Screening Easy Jill Grimes, MD Disclaimer This presentation reflects the opinions of Jill Grimes, MD, and is not intended to represent the opinions of the Seton family of hospitals.
Management of culture positive urinary tract infections in children aged 0-16 years: An audit conducted in a District General Hospital in the United Kingdom *S Jeyabalan 1, E. Ikpakwu 2, G Liyanage 3 Sri
Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).
C H A P T E R Painful Micturition and Increased Frequency of Micturition 1 1 Patients may complain of a painful or burning sensation when they pass urine or may tell you that the number of times that they
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
Original Article Asian Journal of Andrology (2009) 11: 461 477 2009 AJA, SIMM & SJTU All rights reserved 1008-682X/09 $ 32.00 www.nature.com/aja : diagnostic and therapeutic implications 461 Vittorio Magri
Treatment of Urinary Tract Infections in Geriatric Patients Spencer H. Durham, Pharm.D.,BCPS (AQ-ID) Assistant Clinical Professor Department of Pharmacy Practice Auburn University Harrison School of Pharmacy
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/
STD Section Services for Providers and Gonorrhea Update Susan Philip, MD MPH Director, STD Prevention and Control Services San Francisco Department of Public Health Assistant Clinical Professor of Medicine
Sexually Transmitted Infections Chlamydia and Gonorrhea Infection Control Education Sessions Bug of the Month Dr. Shauna Hudson, Medical Health Officer Lindsay Bowman, Communicable Disease/Immunization
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships
Penile pain- What s wrong, doc? Lincoln Tan Registrar The Good Penile pain associated with symptoms or signs consistent with common causes e.g STDs, UTIs The Bad Chronic penile pain without other features
Commensal and Pathogenic Microbial Flora in Humans Medical microbiology is the study of interactions between humans and microorganisms such as bacteria, viruses, fungi and parasites. Although the primary
Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults A Systematic Review (Cochrane database August 2013) Gail Lusardi, Senior Lecturer Dr Allyson Lipp, Principal Lecturer, Dr Chris
Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN
Bacterial Classification and Disease Purpose To provide an overview of how physicians think when confronted with a bacterial infection To alert you to the importance of bacterial classification in treatment
QUICK REFERENCE GUIDE Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Jon Rees, 1 Mark Abrahams, 2 Victor Abu, 3 Trevor
Phase I Study Results Super-strength, freeze-dried Aloe vera capsules for interstitial cystitis, painful bladder syndrome, chronic pelvic pain, and nonbacterial prostatitis Czarapata, B. J. (1995, October).
Homeopathic Treatment of Urethritis Thomas A. Kruzel, N. D. Urethritis or inflammation of the urethra (the tube leading from the bladder to the outside of the body) is a very common condition. Physicians
A THREE YEAR REVIEW OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS REPORTED TO THE NATIONAL HEALTHCARE SAFETY NETWORK AT A TERTIARY CARE HOSPITAL by Jessi Marie Bond BS, Clinical Laboratory Science, Idaho
CLINICAL MICROBIOLOGY REVIEWS, JUly 1988, p. 268-280 Vol. 1, No. 2 0893-8512/88/030268-13$02.00/0 Copyright C) 1988, American Society for Microbiology Detection of Urinary Tract Infections by Rapid Methods
Antibiotics in sepsis Jennifer Curello, PharmD, BCPS Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center September 13, 2013 Outline Sepsis definitions The sepsis bundle Timing of antimicrobials
This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email email@example.com TREATMENT OF STI CONTACTS
Page 1 of 8 TITLE: SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS GUIDELINE: Antibiotics are administered prior to surgical procedures to prevent surgical site infections. PURPOSE:
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Ground K 1, Jones W 2, Gahm G 3, Drake C 2, Min S-J 2, Trautner B 4, Wald HL 2 1 Duke University Hospital, 2 University of Colorado School of Medicine, 3 Vivage, 4 Baylor College of Medicine/Houston VA
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
Fungal Infection in Total Joint Arthroplasty Dr.Wismer Dr.Al-Sahan Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the Literature David M.
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest
Melissa Laudano Protocol Submission, ICCR Rotation August 6, 2007 Antibacterial perineal wash as prophylaxis for recurrent urinary tract infections in a female pediatric population A. Study Purpose and
GUIDELINES ON UROLOGICAL INFECTIONS (Limited text update March 2015) M. Grabe (Chair), R. Bartoletti, T.E. Bjerklund Johansen, M. Çek, B. Köves (Guidelines Associate), K.G. Naber, R.S. Pickard, P. Tenke,
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Jon Rees, 1 Mark Abrahams, 2 Victor Abu, 3 Trevor Allan, 4 Andrew Doble,
This decision support tool is effective as of February 2014. For more information or to provide feedback on this or any other decision support tool, email firstname.lastname@example.org GONORRHEA (REPORTABLE)
Urinary Tract Infections Magdalena Sobieszczyk, MD MPH Division of Infectious Diseases Columbia University Clinical Scenario #1 23 y.o woman presents to her doctor complaining of 1 day of increased urinary
SPECIMEN COLLECTION GUIDE USER GUIDE FOR SPECIMEN COLLECTION MICROBIOLOGY AND MOLECULAR DIAGNOSTIC SERVICES ACM Medical Laboratory offers a comprehensive menu of Microbiology and Molecular Diagnostic services
PROSTATITIS SYMPTOM INDEX Development and Use of a Validated Outcome Measure for Chronic Prostatitis J. Curtis Nickel, MD, FRCSC, Mary McNaughton Collins, MD, MPH, and Mark S. Litwin, MD, MPH Prostatitis
Treatment of Chronic Prostatitis and Prostatodynia with Pollen Extract A. C. Buck, R. W. M. Rees, L. Ebeling * Published in Brit.J. Urol. 64 (1989) 496-499 The treatment of chronic, relapsing nonbacterial
THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon
The Prostate Owner s Manual F A C T S H E E T What you Should Know about the Prostate Only men have a prostate. A part of the male reproductive system, the prostate is located just below the bladder. It
Don t Go With The Flow! Control and Management of UTIs in the Elderly Acknowledgements Central West Infection Control Network Toronto Central Infection Control Network Erie St Clair Infection Control Network
MIBIE Summer School 2014 Molecular diagnostics of UTI & STI by using PCR, DHPLC and NGS Eugen Domann Institute for Medical Microbiology Justus-Liebig University Gießen Human microbiome 14 Superorganism
Urinary Tract Infections Symptomatic and asymptomatic UTI s are a common problem > 10 million office visits per year > 1 million hospital admissions per year Cause of significant nosocomial morbidity Affects
Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis Prostate Cancer and Prostatic Diseases (1999) 2, 159±163 ß 1999 Stockton Press All rights reserved 1365±7852/99
URINARY TRACT INFECTIONS Beryl Navti SEPT Pharmacy Department The Genitourinary System The organs system of the reproductive organs and urinary system Grouped dtogether th because of their proximity it
TO SEND OR NOT TO SEND? THE ROLE OF URINE CULTURES IN UNCOMPLICATED UTI Patricia Moriarty, MSN, FNP-BC, APRN June 3, 2016 OBJECTIVES 1. List the indications for a urine culture. 2. Define an uncomplicated
What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for
Could bacteriuria hold the key to understanding urgency/ urge incontinence 8:15 to 8:20min: Prof Kate Moore, introduction and welcome 8:20-8:35: Dr Colin Walsh 8:35-8:45: Discussion 8:45-9.00: Dr Kylie
CHLAMYDIA CERVICITIS/URETHRITIS AND NON-GONOCOCCAL URETHRITIS (NGU) DEFINITION SUBJECTIVE Infection of the cervix or urethra with Chlamydia trachomatis (CT). Chlamydia infection is a leading cause of acute
Patient Group Direction The supply of Azithromycin 1g as a single dose by accredited Community Pharmacists to patients in receipt of a positive test result to Chlamydia trachomatis, and treatment of their
C H A P T E R 1 Prostatitis Mary McNaughton-Collins, MD, MPH Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital Boston, Massachusetts Geoffrey F. Joyce, PhD Economist
PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL Public Health Action 1. Educate the public, particularly parents of infants, about the dangers of whooping cough and the advantages of initiating immunization
(2012) 14, 870 874 ß 2012 AJA, SIMM & SJTU. All rights reserved 1008-682X/12 $32.00 www.nature.com/aja ORIGINAL ARTICLE Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic
COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS Principal investigator: Dr Francesc Gudiol Munté Bellvitge University
82 Urinary Tract Infection Update Kim Gibson, MD Joseph Toscano, MD Abstract Urinary tract infections are commonly treated in urgent care practice. Clinicians need to be aware of the advantages and limitations
STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):
Genitourin Med 1996;72:93-97 Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises 93 E M Thorpe Jr, W E Stamm, E W Hook III,
Article Patient-Initiated Treatment of Uncomplicated Recurrent Urinary Tract Infections in Young Women Kalpana Gupta, MD, MPH; Thomas M. Hooton, MD; Pacita L. Roberts, MS; and Walter E. Stamm, MD Background: